Accepted for/Published in: JMIR Research Protocols
Date Submitted: Sep 21, 2020
Date Accepted: Apr 13, 2021
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Evaluation of Urinary Exosomes’ Presence for Liquid Biopsy of Clear Cell Renal Cell Carcinoma
ABSTRACT
Background:
About 70-80% of kidney cancers are clear cell renal cell carcinomas (CCRCC). Patient management is based on imaging (abdominal ultrasound and computerized tomography), surgical excision of the tumor and pathological analysis. A tissue biopsy is therefore necessary to confirm the diagnosis and avoid unnecessary nephrectomy. For metastatic cancers, a tissue biopsy is essential for establishing the targeted therapy. This biopsy of tumor material is invasive and painful. Other techniques like liquid biopsy would help reduce tissue biopsy. The development of a simple biological test for diagnosis is essential. CA9 is a powerful marker for the diagnosis of clear cell renal cell carcinoma (CCRCC). Exosome has become a major source of liquid biopsy because they carry tumor protein, RNA and lipids. Urine is the most convenient biological liquid.
Objective:
The aim of this study (PEP-C) is mainly to determine whether it is possible to detect urinary exosomal CA9 for the molecular diagnosis of CCRCC.
Methods:
This study will include 60 patients with CCRCC and 40 non-cancer patients. Exosomes will be isolated from urine samples and exosomal CA9 will be detected by transmission electron microscopy, flow cytometry and RT-qPCR.
Results:
This study is currently underway with funding support from the CHU Saint-Etienne of France.
Conclusions:
We expect to demonstrate that urinary exosomal CA9 could be a novel liquid biopsy to diagnose CCRCC and to guide clinicians in treatment decision-making. Clinical Trial: NCT04053855. Registered August 13, 2019,
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.